VTAK Catheter Precision Inc Forecast, Technical & Fundamental Analysis
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP... Show more
VTAK is expected to report earnings to rise 457.18% to -1900 cents per share on August 17
Q2'26
Est.
$-19.00
Q4'25
Missed
by $3.55
Q3'25
Missed
by $1.78
Q2'25
Missed
by $0.40
Q1'25
Missed
by $0.41
The last earnings report on March 31 showed earnings per share of -341 cents, missing the estimate of 14 cents. With 3.09M shares outstanding, the current market capitalization sits at 2.34M.
A.I. Advisor
published General Information
General Information
a developer of excimer lasers for the treatment of dermatologic and cardiovascular diseases
A.I.dvisor tells us that VTAK and PRPO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and PRPO's prices will move in lockstep.
The 10-day RSI Oscillator for VTAK moved out of overbought territory on June 11, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VTAK as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for VTAK turned negative on June 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
VTAK moved below its 50-day moving average on June 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for VTAK crossed bullishly above the 50-day moving average on June 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTAK advanced for three days, in of 181 cases, the price rose further within the following month. The odds of a continued upward trend are .
VTAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 40 cases where VTAK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.245) is normal, around the industry mean (10.753). P/E Ratio (0.026) is within average values for comparable stocks, (61.509). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.702). VTAK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.162) is also within normal values, averaging (23.786).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VTAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
